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Abstract
Background: The objective of this study was to determine whether major depressive episodes
(MDE) contribute to a lower rate of participation in three prevention activities: blood pressure
checks, mammograms and Pap tests.
Methods: The data source for this study was the Canadian National Population Health Survey
(NPHS), a longitudinal study that started in 1994 and has subsequently re-interviewed its
participants every two years. The NPHS included a short form version of the Composite
International Diagnostic Interview (CIDI-SF) to assess past year MDE and also collected data on
participation in preventive activities. Initially, we examined whether respondents with MDE in a
particular year were less likely to participate in screening during that same year. In order to assess
whether MDE negatively altered the pattern of participation, those successfully screened at the
baseline interview in 1994 were identified and divided into cohorts depending on their MDE status.
Proportional hazard models were used to quantify the effect of MDE on subsequent participation
in screening.
Results: No effect of MDE on participation in the three preventive activities was identified either
in the cross-sectional or longitudinal analysis. Adjustment for a set of relevant covariates did not
alter this result.
Conclusion:  Whereas MDE might be expected to reduce the frequency of participation in
screening activities, no evidence for this was found in the current analysis. Since people with MDE
may contact the health system more frequently, this may offset any tendency of the illness itself to
reduce participation in screening.
Background
The health belief model originated from Hochbaum's
report on X-ray screening for tuberculosis [1]. Modern
applications of this model in public health emphasize
cognitive processes, motivation and self-efficacy [2]. Since
negative cognitive style, diminished motivation and
diminished self-efficacy are all clinical manifestations of
major depressive episodes (MDE), the Health Belief
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Model leads to the hypothesis that depressive disorders
would reduce participation in preventive activities. Intui-
tion also suggests that symptoms such as hopelessness
and fatigue would diminish participation. Clinical studies
have reported results broadly consistent with this hypoth-
esis [3-5] but most community-based studies of screening
participation have failed to evaluate the role of depression
[6-9] or have used only depressive symptom ratings
[10,11]
One study conducted in a US primary care setting found
no differences in the rate of mammography between
women with hypertension and women diagnosed with
depression [12]. Kaida et al. [13] examined determinants
of Pap testing in a study that included an assessment of
MDE based on a short form version of the Composite
International Diagnostic Interview (CIDI-SF) [14]. An
age-interaction was found in this analysis suggesting that
depression may be associated with reduced testing in the
40 to 59 year age group, but depressed women 18 to 39
years old had an increased frequency of testing. In one
study of military veterans, psychiatric disorders were asso-
ciated with a lower level of participation in preventive
activities (including mammography and Pap tests), but
the specific role of MDE was not addressed in this study
[15].
One study using a depressive symptom rating scale (rather
than a diagnostic measure of major depression) found
that high levels of depressive symptoms reduced mam-
mography screening by a modest extent, but had no
impact on Pap tests [16]. Another study of mammography
participation found that people with depressive symp-
toms were less likely to respond to a mammography
screening invitation [10]. Apparently, no studies have
sought to determine whether depressive disorders may
influence the receipt of blood pressure checks.
Overall, there is surprisingly little available information
about the possible role of depressive disorders as a barrier
to participation in screening activities in community pop-
ulations. The objective of this study was to evaluate the
association between MDE and participation in screening
activities in a Canadian population sample. We were
interested in whether reduced participation in screening
was associated with depressive episodes during years
when episodes occurred, and also in whether MDE dis-
rupts ongoing screening.
Methods
The National Population Health Survey
The data source for this analysis was a Canadian study
called the National Population Health Survey (NPHS).
The NPHS is a longitudinal study based on a nationally
representative community sample assembled by Statistics
Canada (Canada's national statistical agency) in 1994/
1995. Detailed information about NPHS methods may be
found on the Statistics Canada Web page http://www.Stat
Can.gc.ca.
The target population for the NPHS consisted of house-
hold residents in the ten Canadian provinces, comprising
98% of the national population. Residents of institutions,
homeless persons, people living on Indian Reserves,
Crown Lands or Armed Forces Bases were excluded from
the sampling frame. Some remote areas in Ontario and
Quebec were also excluded. The NPHS employed a strati-
fied two-stage sample design (clusters, dwellings) based
on sampling frames developed in previous studies (a
national survey called the Labour Force Survey in all prov-
inces except Quebec and in Quebec a survey called the
Enquête sociale et de santé). A respondent was then ran-
domly sampled from the selected dwellings. To correct for
design effects resulting from clustering and stratification
in the sampling procedure, Statistics Canada recommends
a bootstrap procedure that uses a set of 500 replicate sam-
pling weights that they calculate and supply to researchers
for this purpose.
The NPHS cohort has been interviewed every two years
since the initiation of the study, in 1996, 1998, 2000,
2002 and 2004 (data from "cycle 7" collected in 2006
were not available at the time of this analysis). Available
data therefore covered a ten year period between1994 and
2004. Response rates ranged from 92.8% in 1996 to
77.6% in 2004. Item non-response was generally less than
1% during follow-up. Refusal rates during follow-up
ranged from 3.1% and 8.3% per cycle and between 1.7%
and 5.9% per cycle were lost to follow-up because they
could not be located. By the sixth cycle in 2004 (the end-
point for the current analysis), 1,680 of the original
respondents were deceased, 144 had been institutional-
ized and 3,862 were classified as non-respondents due to
loss to follow-up (refusal or failure to trace). An attrition
analysis for the NPHS was reported by Beaudet et al. [17].
Attrition was found to be related to several variables, but
not to MDE. This is consistent with the literature of pro-
spective psychiatric epidemiological studies. MDE may
increase loss to follow-up by mechanisms such as "unable
to locate," but tends to decrease the frequency of refusal,
such that the net effect on attrition is weak [18,19]. The
NPHS is compliant with the Helsinki guidelines. The anal-
ysis of NPHS data reported in this paper was approved by
the University of Calgary Conjoint Health Ethics Review
Board.
The NPHS is a general health survey with broad topical
coverage: data concerning health status, health determi-
nants and health care utilization are collected. Interviews
are conducted using Computer Assisted Interviewing pro-BMC Public Health 2009, 9:87 http://www.biomedcentral.com/1471-2458/9/87
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cedures and carried out by well-trained and experienced
interviewers. In the baseline survey approximately 75% of
the interviews were conducted in-person but in subse-
quent cycles approximately 95% of interviews were con-
ducted over the phone. It is not possible to report the
number of items in the interview since it contains skips
(e.g. the depression module contained a skip if one of two
symptoms required by the DSM-IV criteria were not
present) and eligibility for some questions was age and/or
sex specific. However, the NPHS interviews generally
lasted less than one hour.
The longitudinal cohort included 17,276 participants of
any age, but the analyses reported here are restricted to rel-
evant age and sex groups for each of the three preventive
activities examined: blood pressure checks (age greater
than 45 years, n = 6388), mammography (women aged
50 – 69 years, n = 1868) and pap tests (women 18 years
old or older, n = 7661). Two thousand twenty two chil-
dren (age < 12) were excluded from the current analysis.
Assessment of Major Depression
The NPHS interview included the Composite Interna-
tional Diagnostic Interview Short Form (CIDI-SF) [14] for
MD, which assesses past year major depressive episodes.
This is the same instrument used in the Kaida et al. study
[13]. The CIDI-SF uses a point-based scoring algorithm
that incorporates the number of symptom-based criteria
fulfilled and the necessity for at least one of two key symp-
toms (depressed mood and loss of interest or pleasure) in
keeping with the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) [20]. A score of 5 on the CIDI-
SF is also consistent with DSM-IV-defined MD on the
basis of face validity since the manual requires fulfillment
of five of nine specified symptoms, including at least one
of the two key symptoms. Furthermore, this cut-point
maximized performance of the CIDI-SFMD in a DSM-
IIIR-based receiver operator curve analysis carried out dur-
ing the instrument's development [14]. The CIDI-SFMD
has produced credible prevalence estimates during appli-
cations in Canada [21,22], the US [23,24] and elsewhere
[25]. In the NPHS and CCHS surveys the CIDI-SMFD has
consistently replicated the expected pattern and strength
of association with demographic and clinical variables
[22,26-28]. Furthermore, incidence estimates from the
CIDI-SFMD [27,28] are consistent with those of a system-
atic review by Waraich et al. [29].
Measurement of Participation in Preventive Health 
Activities
Three preventive health procedures have been measured
in each cycle of the NPHS: blood pressure checks, mam-
mography and Pap tests. Notably, these are procedures for
which self-report data generally agree well with medically
recorded information [30]. King et al. reported 94% posi-
tive and 100% negative predictive values for self-reported
mammography [31]. Tisnado et al. also reported high
positive and negative predictive values for mammography
(88% and 91%) and for Pap tests (93% and 85%) [32].
Inconsistency in self-reported mammography data [33]
can be largely explained by problems recalling the dates,
rather than whether the procedure was done [34].
NPHS items assessing preventive procedures were similar
for each of the three procedures examined. In the case of
blood pressure checks, the item was: "Now a few ques-
tions about your use of health care services. Have you ever
had your blood pressure checked?" If the response was
affirmative, this was followed by "When was the last
time." Successful screening consisted of reporting each of
the three procedures within the preceding year, approxi-
mately consistent with Canadian guidelines [35], see also
http://www.ctfphc.org. In the 1994 baseline NPHS inter-
view, 84% of eligible respondents reported that they had
ever had a Pap test, 60% reported ever having had a mam-
mogram and 96% reported that they had ever had their
blood pressure checked.
Measurement of Additional Variables
Variables considered potential confounders were
included in models in order to determine whether adjust-
ment for these variables altered the observed strength of
association. Selection of variables to be included in the
models was based on a judgment about which variables
are associated with depression and could also plausibly
act as independent determinants of participation in pre-
ventive activities. The list included age, sex, rural place of
residence, education level, a diagnosis of hypertension,
other chronic conditions, income, medication use and
employment status. Younger age, female sex, low income
and unemployed status are associated with MDE in the
NPHS, for example, see analyses reported by Beaudet
[26,27]. Chronic conditions are also associated with MDE
in the NPHS [36,37]. Some other Canadian studies have
also identified weak associations between education level
[38], rural place of residence [28] and MDE, although
NPHS analyses have not. These variables were measured
with standard items in the NPHS interview. The assess-
ment of chronic conditions was based on an item inquir-
ing about professionally diagnosed health conditions:
"Now I would like to ask about certain chronic health condi-
tions which you may have. We are interested in long-term con-
ditions that have lasted, or are expected to last, 6 months or
more and that have been diagnosed by a health professional."
This was followed by a series of specific queries, for exam-
ple, "Do you have high blood pressure?" The interview
included such inquiries into 22 different chronic medical
conditions.BMC Public Health 2009, 9:87 http://www.biomedcentral.com/1471-2458/9/87
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Analysis
We initially examined the effect of MDE on participation
in preventive behaviors using cross-sectional data col-
lected at each of the NPHS interview cycles: 1994, 1996,
1998, 2000, 2002 and 2004. Next, we used proportional
hazard models to examine whether MDE leads to discon-
tinuation of screening activities. The models were fit as
generalized linear models of the binomial family with a
complementary log-log link function using a non-para-
metric approach. Jenkins [39] outlines procedures for
implementation of these analyses in STATA [40]. Models
containing only MDE as a predictor (unadjusted) and
those adjusting for a variety of additional variables were
explored. Interactions between MDE and other covariates
were explored in the multivariate analyses, but no signifi-
cant interactions were found. The NPHS cohort was
divided into MDE and non-MDE groups. MDE was
treated as a time-varying factor. MDE status at the start of
each 2-year incidence interval determined whether a
respondent was in the exposed or non-exposed cohort
during that interval. Respondents who were lost to follow-
up, died or were institutionalized were censored in the
analysis. All analyses were conducted using STATA [40].
Results
Blood Pressure Checks
Cross-sectionally, there was no evidence that people with
MDE fail to receive blood pressure checks more frequently
than those without. In fact, in several cycles the frequency
with which depressed respondents went unscreened was
considerably lower than that of non-depressed respond-
ents, see Table 1.
There were 4813 respondents who reported that they had
their blood pressure checked in the year preceding the
baseline interview. The prevalence of MDE in this group
was 4.1% (95% CI 3.5 – 4.8), comparable to the overall
prevalence of MDE. Of these, n = 348 reported two years
later that they had not had a blood pressure check in the
year preceding that interview. The incidence of entry into
an unscreened state during this initial 2-years of NPHS
follow-up was 8.3% (95% CI 3.0 – 13.6) in those with
MDE and 9.0% (95% CI 7.9 – 10.2) in those without
MDE at the 1994 interview. The high frequency of transi-
tion from screened to unscreened status during the 1994
to 1996 interval was not sustained during subsequent fol-
low-up. The frequency diminished from 6.3% between in
the 1996 to 1998 interval to 1.9% from in the 2002 to
2004 interval.
The unadjusted hazard ratio representing the effect of
MDE on the risk of transition to non-screened status was
0.84 (95% CI 0.5 – 1.4) and was not significantly different
from the null value (Wald test, p = 0.53). In a propor-
tional hazards model that included a variety of covariates
(age, sex, rural place of residence, education level, a diag-
nosis of hypertension, other chronic conditions, income
and employment status) it was found that reporting a
diagnosis of high blood pressure greatly reduced the risk
of discontinued screening (HR = 0.2, p < 0.001). Other
variables likely to be related to health care use were also
associated with a reduced risk of discontinued screening:
a diagnosis of any other chronic condition (HR = 0.6, p <
0.001), female sex (HR = 0.8, p = 0.05) and age 66+ (HR
= 0.6, p < 0.001). All of these variables can be regarded as
potential confounders since they are associated with the
transition to non-screened status. However, an adjusted
HR for MDE from a model including these variables
resembled the unadjusted one, and did not provide evi-
dence of an association (HR = 0.9, 95% CI 0.5 – 1.6), p =
0.74.
Mammograms
Table 2 presents the frequency with which respondents
reported not having a mammogram during the preceding
year. The estimates vary considerably from cycle to cycle
and the confidence intervals are wide. This reflects dimin-
ished precision resulting from restriction of the analysis to
the eligible age and sex group. Only the 2000 and 2004
results suggest a possible association, and these effects are
Table 1: Blood Pressure Checks: Proportion of eligible NPHS 
respondents (n) failing to be screened in the preceding year, by 





1994 5,847 14.2 (8.0–20.3) 20.0 (18.6–21.4)
1996 5,395 9.2 (3.7–14.7) 16.0 (14.7–17.3)
1998 4,900 6.1 (1.6–10.6) 13.3 (12.0–14.6)
2000 4,247 5.6 (1.0–10.1) 10.1 (8.9–11.3)
2002 3,714 5.8 (0.8–10.9) 8.8 (7.6–10.0)
* 2004 estimates could not be released according to Statistics Canada 
guidelines, due to imprecision. These estimates include all eligible (age 
> 45) respondents irrespective of whether they had a blood pressure 
check at baseline.
Table 2: Mammograms: Proportion of eligible NPHS 
respondents (n) failing to be screened in the preceding year, by 





1994 1,283 55.2 (39.9–70.6) 47.8 (44.2–51.4)
1996 1,304 32.9 (17.7–48.2) 47.9 (44.5–51.3)
1998 1,310 50.3 (31.7–68.9) 44.0 (40.2–47.8)
2000 1,252 24.4 (8.7–40.1) 46.8 (43.2–50.4)
2002 1,149 43.3 (22.7–63.8) 51.1 (47.5–54.8)
2004 1,107 74.4 (58.3–90.5) 51.4 (47.3–55.4)
*These estimates include all eligible respondents (women aged 50 – 
69) irrespective of whether they had a mammogram in the year 
preceding the baseline interview.BMC Public Health 2009, 9:87 http://www.biomedcentral.com/1471-2458/9/87
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in opposite directions. In 2000, the frequency of failed
screening was higher in those with MDE, but in 2004 it
was lower.
There were 669 women who reported having a mammo-
gram in the 12 months preceding the 1994 interview.
Transition to unscreened status was defined as failure to
report having a mammogram in the year preceding the
next interview. This transition occurred at a frequency of
33.3% (95% CI between 1994 and 1996) and remained >
20% at each subsequent cycle. There was no evidence of
an effect of age, as the frequency of discontinuation in the
initial interval (1994 to 1996) was comparable in the 50–
59 age category (31.2%, 95% CI 25.2 – 37.3) as in the 60–
69 age category (36.3% 95% CI 28.6 – 43.9).
The unadjusted HR was not significantly elevated: HR =
1.2 (95% CI 0.8 – 1.8), Wald test, p = 0.42. In propor-
tional hazards modeling, the same set of covariates
employed in the blood pressure checks analysis (see pre-
vious section) were included, except for sex. Also, receipt
of hormone replacement therapy was included as a covari-
ate in this part of the analysis. However, none of these var-
iables significantly predicted discontinuation of annual
mammograms and their inclusion, either individually or
simultaneously, resulted in no substantial change in the
HR for MDE. The adjusted HR was 0.8 (95% CI 0.4 – 1.6).
Pap Tests
Table 3 presents the frequency of failing to receive a Pap
test at each of the six NPHS cycles in eligible respondents
with and without MDE. Due to inclusion of a larger set of
respondents, the estimates are more precise than that seen
in the mammography analysis. In no instance do the
point estimates or confidence intervals provide evidence
of a cross-sectional association between MDE and Pap
tests.
There were n = 3,392 who reported having a Pap test dur-
ing the year preceding the 1994 interview. By 1996, n =
902 reported not having been screened. The frequency of
discontinuation in this initial follow-up period in those
with MDE (30.5%, 95% CI 23.5 – 37.5) resembled that of
respondents without MDE (28.9%, 95% CI 26.5 – 31.2).
The unadjusted HR over the entire follow-up interval was
1.3 (95% CI 0.9 – 1.4), which was not statistically signifi-
cant (Wald test, p = 0.31). Inclusion of covariates (age
group, rural residence, oral contraceptive use, hormone
replacement therapy, having one or more chronic condi-
tions, low income and current employment) did not alter
the observed (lack of) association. Both age and oral con-
traceptive use were associated with discontinuation of
screening. The HR for oral contraceptive use was 0.6, 95%
CI 0.5 – 0.8). Contrary to the results reported by Kaida et
al. [13], no interactions between MDE and age were iden-
tified. This may be due to the smaller sample size in the
NPHS as compared to the dataset analyzed by Kaida et al.
With adjustment for this set of covariates, the adjusted HR
quantifying the association between MDE and failure to
have a Pap test resembled the unadjusted HR, 1.2 (95% CI
0.9 – 1.5) and did not achieve statistical significance
(Wald test, p = 0.14).
Discussion
The analyses presented here failed to find evidence that
MDE is an important determinant of participation in
three preventive health care activities. These results are in
some respects counter-intuitive since symptoms of
depression would seem capable of interfering with partic-
ipation in screening activities. However, there are a variety
of possible explanations for these results. First, major
depression is associated with a higher frequency of health
care use (both for psychiatric and non-psychiatric serv-
ices) [41,42]. This may result in an increased frequency of
blood pressure checks, mammograms and Pap tests. Sec-
ond, as MDE is often managed using medications, the
need for medication renewals may also lead to increased
contact with physicians. Depressive symptoms, which
have been a focus of most previous studies [10,11,16],
may not have been accompanied by medical interven-
tions to the same extent as MDE, potentially explaining
why some differences in screening participation have
been reported in association with elevated depressive
symptom levels by some prior studies.
There are several limitations of this study. First, whereas
the NPHS assessed participation in three preventive activ-
ities, it was not possible to determine precisely whether
the participation was for preventive purposes as opposed
to treatment purposes. Another limitation is that the
methods of measuring preventive activities in the NPHS
did not necessarily align with levels of participation man-
dated by particular screening guidelines. For example,
guidelines for the frequency of mammography depend on
Table 3: Pap Tests: Proportion of eligible NPHS respondents (n) 






1994 6,282 42.2 (36.1–48.2) 44.8 (43.1–46.4)
1996 6,073 46.0 (38.5–53.4) 44.4 (42.5–46.3)
1998 5,850 45.4 (37.8–52.9) 46.2 (44.4–48.0)
2000 5,518 45.3 (38.5–52.2) 45.2 (43.5–46.8)
2002 5,062 50.5 (42.9–58.0) 48.3 (46.4–50.2)
2004 4,755 55.0 (47.2–62.8) 48.7 (46.8–50.6)
*These estimates include all eligible (women age 18+) respondents 
irrespective of whether they reported having a Pap test at the 
baseline interview.BMC Public Health 2009, 9:87 http://www.biomedcentral.com/1471-2458/9/87
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age and may include recommendations for annual or
biannual screening, but only past year mammography
was consistently available in the NPHS. In addition, the
assessment of participation depended on self-report. Self
report may be vulnerable to error either because proce-
dures were forgotten, or because social desirability biases
favor reported participation. Another issue concerns rep-
resentativeness. The NPHS cohort derives from a general
population sample but factors affecting continued partic-
ipation during follow-up may have diminished its repre-
sentativeness over time. Also, because the longitudinal
components of the current analysis had the goal of clari-
fying temporal effects, prospective analyses were restricted
to those respondents who were in the screened category at
baseline. The prospective results therefore may represent
an initially health-conscious group rather than in the pop-
ulation as a whole. Although the study included adjust-
ment for potential confounding variables, the NPHS is a
general health survey and the variables available for anal-
ysis were limited. In particular, direct measures of psycho-
logical variables relevant to screening behaviors, such as
those identified by the health belief model would have
been valuable to include in the analysis. The HRs for
mammography and Pap tests were slightly elevated,
although these elevations did not achieve statistical signif-
icance. Weak effects may exist and may not have been
detected because of Type II error. They may have achieved
statistical significance had the sample size been larger.
The measure of MDE used in the study, the CIDI-SF, is a
brief predictive interview. It is less detailed than lengthier
versions of the CIDI interview, which may have led to
measurement inaccuracy in some instances. If a substan-
tial degree of misclassification did occur, this could lead
to a dilution of effect. Non-differential misclassification
bias, therefore, remains an alternative explanation for the
largely negative findings reported here. A related observa-
tion concerns the precision of the estimates. Although no
evidence of an effect of MDE on screening participation
was found, some of the confidence intervals included a
range of values that may nevertheless be of public health
significance. As such, the results reported here cannot
entirely exclude the possibility that MDE is a determinant
of screening participation.
Conclusion
If MDE were associated with diminished participation in
preventive health care activities special efforts to increase
or safeguard the participation of people who experience
these episodes would be advisable. However, the current
analysis found no evidence for diminished participation.
Increased contact with the health system, which is associ-
ated with MDE, may offset any tendency of the illness
itself to reduce participation in screening.
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